This is consistent with previous findings that a daily dose of 2.5 mg rarely causes persistent amenorrhea but can significantly affect endometrial development and hormone receptor expression.[28–30] An ultra-low dose of mifepristone can play an active role in the control of uterine fibroids. The gene discussed is NR4A1; the disease is uterine corpus leiomyoma.